I'm thrilled to sit down with Ivan Kairatov, a renowned biopharma expert with extensive experience in research, development, and cutting-edge technology in the industry. Today, we’re diving into an exciting partnership that promises to revolutionize traceability in clinical consumables, focusing on
Ulcerative colitis (UC), a chronic inflammatory bowel disease, affects millions of individuals worldwide, presenting as persistent inflammation in the colon and rectum, often resulting in severe discomfort and a diminished quality of life for those affected. For patients dealing with moderate to
Imagine a world where the shadow of incurable diseases no longer looms over millions, where conditions like Alzheimer’s, heart failure, and spinal cord injuries are not just managed with temporary relief but treated at their very core through therapies that heal at the cellular level. Stem cell
Imagine a world where the brain's fundamental energy processes, long thought to be set in stone, are suddenly redefined by a single discovery that could alter the course of treatment for devastating neurological conditions. Researchers from prestigious institutions have recently unveiled a
I'm thrilled to sit down with Ivan Kairatov, a renowned biopharma expert whose extensive experience in research, development, and innovation has positioned him as a thought leader in the cell and gene therapy (CGT) industry. With a sharp focus on emerging technologies and strategic growth, Ivan
The realm of cell and gene therapies (CGTs) has long been heralded as a revolutionary frontier in medicine, promising transformative outcomes for patients with previously untreatable conditions, yet it faces significant hurdles in securing consistent funding. As the industry matures, it confronts a
